Influence of methamphetamine on genital herpes simplex virus type 2 infection in a mouse model

Sexually Transmitted Diseases

Volumn 39, Issue 9, 2012, Pages 720-725

  Valencia, Frances ^a,b   Bubar, Marcy J ^b   Milligan, Gregg ^b   Cunningham, Kathryn A ^b   Bourne, Nigel ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; GENITAL HERPES SIMPLEX VIRUS TYPE 2 INFECTION; INNATE IMMUNITY; MOUSE; NONHUMAN; PATHOGENESIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS CULTURE; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; IMMUNITY, INNATE; METHAMPHETAMINE; MICE; REAL-TIME POLYMERASE CHAIN REACTION; VAGINA;

EID: 84865511708     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31825af129     Document Type: Article

References (23)

1. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction 2009; 104:1085-1099.
2. Urbina A, Jones K. Crystal methamphetamine, its analogues, and HIV infection: Medical and psychiatric aspects of a new epidemic. Clin Infect Dis 2004; 38:890-894.
3. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36:6-10.
4. Colfax G, Guzman R. Club drugs and HIV infection: A review. Clin Infect Dis 2006; 42:1463-1469.
5. Talloczy Z, Martinez J, Joset D, et al. Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog 2008; 4:e28.
6. Corey L. Herpes simplex virus. In: Mandell GL, Bennett JE, Dolin R (eds). Practices of Infectious Diseases. Philadelphia, PA: Elsevier, 2005:1762-1780.
7. Brown ZA, Kern ER, Spruance SL, et al. Clinical and virologic course of herpes simplex genitalis. West J Med 1979; 130:414-421.
8. Corey L, Wald A, Patel R, et al. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350:11-20.
9. Corey L. Synergistic copathogens-HIV-1 and HSV-2. N Engl J Med 2007; 356:854-856.
10. Gisselquist D, Potterat JJ. Uncontrolled herpes simplex virus-2 as a cofactor in HIV transmission. J Acquir Immun Defic Syndr 2003; 33:119-120.
11. Bourne N, Milligan GN, Schleiss MR, et al. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2. Vaccine 1996; 14:1230-1234.
12. Pennock JW, Stegall R, Bubar MJ, et al. 3,4-Methylenedioxy- methamphetamine increases susceptiblity to genital herpes simplex virus infection in mice. J Infect Dis 2009; 200:1247-1250.
13. Pennock JW, Stegall R, Bell B, et al. Estradiol improves genital herpes vaccine efficacy in mice. Vaccine 2009; 27:5830-5836.
14. Bourne N, Milligan GN, Stanberry LR, et al. Impact of immunization with glycoprotein D2/AS04 on herpes simplex virus type 2 shedding into the genital tract in guinea pigs that become infected. J Infect Dis 2005; 192:2117-2123.
15. Corey L, Huang ML, Selke S, et al. Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay. J Med Virol 2005; 76:350-355.
16. Harandi AM, Eriksson K, Holmgren J. A protective role of locally administered immunostimulatory CpG oligodeoxynucle-otide in a mouse model of genital herpes infection. J Virol 2003; 77:953-962.
17. Zhao X, Deak E, Soderberg K, et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 2003; 197:153-162.
18. Conrady CD, Halford WP, Carr DJ. Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection. J Virol 2011; 85:1625-1633.
19. In SW, Son EW, Rhee DK, et al. Modulation of murine macro-phage function by methamphetamine. J Toxicol Environ Health A 2004; 67:1923-1937.
20. Yu Q, Zhang D, Walston M, et al. Chronic methamphetamine exposure alters immune function in normal and retrovirus-in-fected mice. Int Immunopharmacol 2002; 2:951-962.
21. Martinez LR, Mihu MR, Gacser A, et al. Methamphetamine enhances histoplasmosis by immunosuppression of the host. J Infect Dis 2009; 200:131-141.
22. Lekstrom-Himes JA, Pesnicak L, Straus SE. The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks. J Virol 1998; 72:2760-2764.
23. Bourne N, Bravo FJ, Francotte M, et al. Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs. J Infect Dis 2003; 187:542-549.